-
Pancreatic cancer in 2026: beyond chemotherapy—emerging modalities and clinical integration
How are treatment decisions evolving in pancreatic cancer? Explore real-world challenges, emerging therapies, and multidisciplinary strategies in advanced disease.
-
Closing the communication gap in ICU care
Test your knowledge of communication gaps among ICU clinicians, patients, and caregivers, including PICS awareness, shared decision-making, and patient-centered care.
-
Frontline myeloma: does depth of response change what comes next?
In newly diagnosed and transplant-ineligible multiple myeloma, deeper responses are increasingly achieved with immune-based regimens. How are you approaching treatment decisions, sequencing, duration, and patient-centered care in this evolving setting?
-
Physician-Scientists and Team Science: A Workforce Innovation Quiz
Test your knowledge of physician-scientist contributions, NIH funding trends, team science strategies, and training pathways shaping the future of academic medicine.
-
Refractory cGVHD: Mechanisms, Escalation, and 3L Decision-Making
Assess your knowledge of escalation beyond JAK inhibition in cGVHD. Explore inflammatory vs fibrotic mechanisms, 2L+ clinical trial outcomes, and emerging real-world insights in third-line management.
-
Lung Cancer Decision Points: Sequencing Care After Surgery and Chemoradiation
Key lung cancer decisions often arise after surgery or chemoradiation. Explore how treatment sequencing, immune-based concepts, patient fatigue, and disease biology shape ongoing care across NSCLC and SCLC.
